Global Prescription Dermatological Drugs Market Insights and Forecast to 2026

Global Prescription Dermatological Drugs Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Prescription Dermatological Drugs Product Introduction
1.2 Market Segments
1.3 Key Prescription Dermatological Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Prescription Dermatological Drugs Market Size Growth Rate by Type
1.4.2 Anti-acne Drugs
1.4.3 Anti-aging Drugs
1.4.4 Dermatitis Drugs
1.4.5 Hair Loss Drugs
1.4.6 Psoriasis Drugs
1.4.7 Skin Cancer Drugs
1.4.8 Melasma Drugs
1.4.9 Seborrhea Drugs
1.5 Market by Application
1.5.1 Global Prescription Dermatological Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Prescription Dermatological Drugs Market Size, Estimates and Forecasts
2.1.1 Global Prescription Dermatological Drugs Revenue 2015-2026
2.1.2 Global Prescription Dermatological Drugs Sales 2015-2026
2.2 Global Prescription Dermatological Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Prescription Dermatological Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Prescription Dermatological Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Prescription Dermatological Drugs Competitor Landscape by Players
3.1 Prescription Dermatological Drugs Sales by Manufacturers
3.1.1 Prescription Dermatological Drugs Sales by Manufacturers (2015-2020)
3.1.2 Prescription Dermatological Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Prescription Dermatological Drugs Revenue by Manufacturers
3.2.1 Prescription Dermatological Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Prescription Dermatological Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Prescription Dermatological Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Prescription Dermatological Drugs Revenue in 2019
3.2.5 Global Prescription Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Prescription Dermatological Drugs Price by Manufacturers
3.4 Prescription Dermatological Drugs Manufacturing Base Distribution, Product Types
3.4.1 Prescription Dermatological Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Prescription Dermatological Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Prescription Dermatological Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Prescription Dermatological Drugs Market Size by Type (2015-2020)
4.1.1 Global Prescription Dermatological Drugs Sales by Type (2015-2020)
4.1.2 Global Prescription Dermatological Drugs Revenue by Type (2015-2020)
4.1.3 Prescription Dermatological Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Prescription Dermatological Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Prescription Dermatological Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Prescription Dermatological Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Prescription Dermatological Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Prescription Dermatological Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Prescription Dermatological Drugs Market Size by Application (2015-2020)
5.1.1 Global Prescription Dermatological Drugs Sales by Application (2015-2020)
5.1.2 Global Prescription Dermatological Drugs Revenue by Application (2015-2020)
5.1.3 Prescription Dermatological Drugs Price by Application (2015-2020)
5.2 Prescription Dermatological Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Prescription Dermatological Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Prescription Dermatological Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Prescription Dermatological Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Prescription Dermatological Drugs by Country
6.1.1 North America Prescription Dermatological Drugs Sales by Country
6.1.2 North America Prescription Dermatological Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Prescription Dermatological Drugs Market Facts & Figures by Type
6.3 North America Prescription Dermatological Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Prescription Dermatological Drugs by Country
7.1.1 Europe Prescription Dermatological Drugs Sales by Country
7.1.2 Europe Prescription Dermatological Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Prescription Dermatological Drugs Market Facts & Figures by Type
7.3 Europe Prescription Dermatological Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Prescription Dermatological Drugs by Region
8.1.1 Asia Pacific Prescription Dermatological Drugs Sales by Region
8.1.2 Asia Pacific Prescription Dermatological Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Prescription Dermatological Drugs Market Facts & Figures by Type
8.3 Asia Pacific Prescription Dermatological Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Prescription Dermatological Drugs by Country
9.1.1 Latin America Prescription Dermatological Drugs Sales by Country
9.1.2 Latin America Prescription Dermatological Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Prescription Dermatological Drugs Market Facts & Figures by Type
9.3 Central & South America Prescription Dermatological Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Prescription Dermatological Drugs by Country
10.1.1 Middle East and Africa Prescription Dermatological Drugs Sales by Country
10.1.2 Middle East and Africa Prescription Dermatological Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Prescription Dermatological Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Prescription Dermatological Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Prescription Dermatological Drugs Products Offered
11.1.5 Johnson & Johnson Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Prescription Dermatological Drugs Products Offered
11.2.5 Merck Related Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Description and Business Overview
11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer Prescription Dermatological Drugs Products Offered
11.3.5 Bayer Related Developments
11.4 Mylan Pharmaceuticals
11.4.1 Mylan Pharmaceuticals Corporation Information
11.4.2 Mylan Pharmaceuticals Description and Business Overview
11.4.3 Mylan Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Mylan Pharmaceuticals Prescription Dermatological Drugs Products Offered
11.4.5 Mylan Pharmaceuticals Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Prescription Dermatological Drugs Products Offered
11.5.5 Pfizer Related Developments
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Corporation Information
11.6.2 F. Hoffmann-La Roche Description and Business Overview
11.6.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.6.4 F. Hoffmann-La Roche Prescription Dermatological Drugs Products Offered
11.6.5 F. Hoffmann-La Roche Related Developments
11.7 Allergan
11.7.1 Allergan Corporation Information
11.7.2 Allergan Description and Business Overview
11.7.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Allergan Prescription Dermatological Drugs Products Offered
11.7.5 Allergan Related Developments
11.8 Bausch Health
11.8.1 Bausch Health Corporation Information
11.8.2 Bausch Health Description and Business Overview
11.8.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bausch Health Prescription Dermatological Drugs Products Offered
11.8.5 Bausch Health Related Developments
11.9 PharmaDerm Pharmaceuticals
11.9.1 PharmaDerm Pharmaceuticals Corporation Information
11.9.2 PharmaDerm Pharmaceuticals Description and Business Overview
11.9.3 PharmaDerm Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Products Offered
11.9.5 PharmaDerm Pharmaceuticals Related Developments
11.10 Allergan Inamed Corporation
11.10.1 Allergan Inamed Corporation Corporation Information
11.10.2 Allergan Inamed Corporation Description and Business Overview
11.10.3 Allergan Inamed Corporation Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Allergan Inamed Corporation Prescription Dermatological Drugs Products Offered
11.10.5 Allergan Inamed Corporation Related Developments
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Prescription Dermatological Drugs Products Offered
11.1.5 Johnson & Johnson Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Prescription Dermatological Drugs Market Estimates and Projections by Region
12.1.1 Global Prescription Dermatological Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Prescription Dermatological Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Prescription Dermatological Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Prescription Dermatological Drugs Sales Forecast (2021-2026)
12.2.2 North America: Prescription Dermatological Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Prescription Dermatological Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Prescription Dermatological Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Prescription Dermatological Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Prescription Dermatological Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Prescription Dermatological Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Prescription Dermatological Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Prescription Dermatological Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Prescription Dermatological Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Prescription Dermatological Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Prescription Dermatological Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Prescription Dermatological Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Prescription Dermatological Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Prescription Dermatological Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Prescription Dermatological Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Prescription Dermatological Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Prescription Dermatological Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Prescription Dermatological Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Prescription Dermatological Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Prescription Dermatological Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Prescription Dermatological Drugs Market Segments
Table 2. Ranking of Global Top Prescription Dermatological Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Prescription Dermatological Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Anti-acne Drugs
Table 5. Major Manufacturers of Anti-aging Drugs
Table 6. Major Manufacturers of Dermatitis Drugs
Table 7. Major Manufacturers of Hair Loss Drugs
Table 8. Major Manufacturers of Psoriasis Drugs
Table 9. Major Manufacturers of Skin Cancer Drugs
Table 10. Major Manufacturers of Melasma Drugs
Table 11. Major Manufacturers of Seborrhea Drugs
Table 12. Global Prescription Dermatological Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Prescription Dermatological Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Prescription Dermatological Drugs Sales by Regions 2015-2020 (K Units)
Table 15. Global Prescription Dermatological Drugs Sales Market Share by Regions (2015-2020)
Table 16. Global Prescription Dermatological Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Prescription Dermatological Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Prescription Dermatological Drugs Sales Share by Manufacturers (2015-2020)
Table 19. Global Prescription Dermatological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Prescription Dermatological Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prescription Dermatological Drugs as of 2019)
Table 21. Prescription Dermatological Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Prescription Dermatological Drugs Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Prescription Dermatological Drugs Price (2015-2020) (USD/Units)
Table 24. Prescription Dermatological Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Prescription Dermatological Drugs Product Type
Table 26. Date of International Manufacturers Enter into Prescription Dermatological Drugs Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Prescription Dermatological Drugs Sales by Type (2015-2020) (K Units)
Table 29. Global Prescription Dermatological Drugs Sales Share by Type (2015-2020)
Table 30. Global Prescription Dermatological Drugs Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Prescription Dermatological Drugs Revenue Share by Type (2015-2020)
Table 32. Prescription Dermatological Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Units)
Table 33. Global Prescription Dermatological Drugs Sales by Application (2015-2020) (K Units)
Table 34. Global Prescription Dermatological Drugs Sales Share by Application (2015-2020)
Table 35. North America Prescription Dermatological Drugs Sales by Country (2015-2020) (K Units)
Table 36. North America Prescription Dermatological Drugs Sales Market Share by Country (2015-2020)
Table 37. North America Prescription Dermatological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Prescription Dermatological Drugs Revenue Market Share by Country (2015-2020)
Table 39. North America Prescription Dermatological Drugs Sales by Type (2015-2020) (K Units)
Table 40. North America Prescription Dermatological Drugs Sales Market Share by Type (2015-2020)
Table 41. North America Prescription Dermatological Drugs Sales by Application (2015-2020) (K Units)
Table 42. North America Prescription Dermatological Drugs Sales Market Share by Application (2015-2020)
Table 43. Europe Prescription Dermatological Drugs Sales by Country (2015-2020) (K Units)
Table 44. Europe Prescription Dermatological Drugs Sales Market Share by Country (2015-2020)
Table 45. Europe Prescription Dermatological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Prescription Dermatological Drugs Revenue Market Share by Country (2015-2020)
Table 47. Europe Prescription Dermatological Drugs Sales by Type (2015-2020) (K Units)
Table 48. Europe Prescription Dermatological Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Prescription Dermatological Drugs Sales by Application (2015-2020) (K Units)
Table 50. Europe Prescription Dermatological Drugs Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Prescription Dermatological Drugs Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Prescription Dermatological Drugs Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Prescription Dermatological Drugs Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Prescription Dermatological Drugs Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Prescription Dermatological Drugs Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Prescription Dermatological Drugs Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Prescription Dermatological Drugs Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Prescription Dermatological Drugs Sales Market Share by Application (2015-2020)
Table 59. Latin America Prescription Dermatological Drugs Sales by Country (2015-2020) (K Units)
Table 60. Latin America Prescription Dermatological Drugs Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Prescription Dermatological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Prescription Dermatological Drugs Revenue Market Share by Country (2015-2020)
Table 63. Latin America Prescription Dermatological Drugs Sales by Type (2015-2020) (K Units)
Table 64. Latin America Prescription Dermatological Drugs Sales Market Share by Type (2015-2020)
Table 65. Latin America Prescription Dermatological Drugs Sales by Application (2015-2020) (K Units)
Table 66. Latin America Prescription Dermatological Drugs Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Prescription Dermatological Drugs Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Prescription Dermatological Drugs Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Prescription Dermatological Drugs Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Prescription Dermatological Drugs Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Prescription Dermatological Drugs Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Prescription Dermatological Drugs Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Prescription Dermatological Drugs Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Prescription Dermatological Drugs Sales Market Share by Application (2015-2020)
Table 75. Johnson & Johnson Corporation Information
Table 76. Johnson & Johnson Description and Major Businesses
Table 77. Johnson & Johnson Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 78. Johnson & Johnson Product
Table 79. Johnson & Johnson Recent Development
Table 80. Merck Corporation Information
Table 81. Merck Description and Major Businesses
Table 82. Merck Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 83. Merck Product
Table 84. Merck Recent Development
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Major Businesses
Table 87. Bayer Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 88. Bayer Product
Table 89. Bayer Recent Development
Table 90. Mylan Pharmaceuticals Corporation Information
Table 91. Mylan Pharmaceuticals Description and Major Businesses
Table 92. Mylan Pharmaceuticals Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 93. Mylan Pharmaceuticals Product
Table 94. Mylan Pharmaceuticals Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Major Businesses
Table 97. Pfizer Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 98. Pfizer Product
Table 99. Pfizer Recent Development
Table 100. F. Hoffmann-La Roche Corporation Information
Table 101. F. Hoffmann-La Roche Description and Major Businesses
Table 102. F. Hoffmann-La Roche Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 103. F. Hoffmann-La Roche Product
Table 104. F. Hoffmann-La Roche Recent Development
Table 105. Allergan Corporation Information
Table 106. Allergan Description and Major Businesses
Table 107. Allergan Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 108. Allergan Product
Table 109. Allergan Recent Development
Table 110. Bausch Health Corporation Information
Table 111. Bausch Health Description and Major Businesses
Table 112. Bausch Health Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 113. Bausch Health Product
Table 114. Bausch Health Recent Development
Table 115. PharmaDerm Pharmaceuticals Corporation Information
Table 116. PharmaDerm Pharmaceuticals Description and Major Businesses
Table 117. PharmaDerm Pharmaceuticals Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 118. PharmaDerm Pharmaceuticals Product
Table 119. PharmaDerm Pharmaceuticals Recent Development
Table 120. Allergan Inamed Corporation Corporation Information
Table 121. Allergan Inamed Corporation Description and Major Businesses
Table 122. Allergan Inamed Corporation Prescription Dermatological Drugs Production (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2015-2020)
Table 123. Allergan Inamed Corporation Product
Table 124. Allergan Inamed Corporation Recent Development
Table 125. Global Prescription Dermatological Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 126. Global Prescription Dermatological Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 127. Global Prescription Dermatological Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 128. Global Prescription Dermatological Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 129. North America: Prescription Dermatological Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 130. North America: Prescription Dermatological Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Europe: Prescription Dermatological Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 132. Europe: Prescription Dermatological Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Asia Pacific: Prescription Dermatological Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 134. Asia Pacific: Prescription Dermatological Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 135. Latin America: Prescription Dermatological Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 136. Latin America: Prescription Dermatological Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Middle East and Africa: Prescription Dermatological Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 138. Middle East and Africa: Prescription Dermatological Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Prescription Dermatological Drugs Players
Table 143. Prescription Dermatological Drugs Customers List
Table 144. Prescription Dermatological Drugs Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Prescription Dermatological Drugs Product Picture
Figure 2. Global Prescription Dermatological Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Anti-acne Drugs Product Picture
Figure 4. Anti-aging Drugs Product Picture
Figure 5. Dermatitis Drugs Product Picture
Figure 6. Hair Loss Drugs Product Picture
Figure 7. Psoriasis Drugs Product Picture
Figure 8. Skin Cancer Drugs Product Picture
Figure 9. Melasma Drugs Product Picture
Figure 10. Seborrhea Drugs Product Picture
Figure 11. Global Prescription Dermatological Drugs Sales Market Share by Application in 2020 & 2026
Figure 12. Hospital Pharmacies
Figure 13. Retail Pharmacies
Figure 14. Online Pharmacies
Figure 15. Prescription Dermatological Drugs Report Years Considered
Figure 16. Global Prescription Dermatological Drugs Market Size 2015-2026 (US$ Million)
Figure 17. Global Prescription Dermatological Drugs Sales 2015-2026 (K Units)
Figure 18. Global Prescription Dermatological Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Prescription Dermatological Drugs Sales Market Share by Region (2015-2020)
Figure 20. Global Prescription Dermatological Drugs Sales Market Share by Region in 2019
Figure 21. Global Prescription Dermatological Drugs Revenue Market Share by Region (2015-2020)
Figure 22. Global Prescription Dermatological Drugs Revenue Market Share by Region in 2019
Figure 23. Global Prescription Dermatological Drugs Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Prescription Dermatological Drugs Revenue in 2019
Figure 25. Prescription Dermatological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Prescription Dermatological Drugs Sales Market Share by Type (2015-2020)
Figure 27. Global Prescription Dermatological Drugs Sales Market Share by Type in 2019
Figure 28. Global Prescription Dermatological Drugs Revenue Market Share by Type (2015-2020)
Figure 29. Global Prescription Dermatological Drugs Revenue Market Share by Type in 2019
Figure 30. Global Prescription Dermatological Drugs Market Share by Price Range (2015-2020)
Figure 31. Global Prescription Dermatological Drugs Sales Market Share by Application (2015-2020)
Figure 32. Global Prescription Dermatological Drugs Sales Market Share by Application in 2019
Figure 33. Global Prescription Dermatological Drugs Revenue Market Share by Application (2015-2020)
Figure 34. Global Prescription Dermatological Drugs Revenue Market Share by Application in 2019
Figure 35. North America Prescription Dermatological Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 36. North America Prescription Dermatological Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Prescription Dermatological Drugs Sales Market Share by Country in 2019
Figure 38. North America Prescription Dermatological Drugs Revenue Market Share by Country in 2019
Figure 39. U.S. Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 40. U.S. Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 42. Canada Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Prescription Dermatological Drugs Market Share by Type in 2019
Figure 44. North America Prescription Dermatological Drugs Market Share by Application in 2019
Figure 45. Europe Prescription Dermatological Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe Prescription Dermatological Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Prescription Dermatological Drugs Sales Market Share by Country in 2019
Figure 48. Europe Prescription Dermatological Drugs Revenue Market Share by Country in 2019
Figure 49. Germany Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. France Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.K. Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. Italy Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 58. Russia Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Prescription Dermatological Drugs Market Share by Type in 2019
Figure 60. Europe Prescription Dermatological Drugs Market Share by Application in 2019
Figure 61. Asia Pacific Prescription Dermatological Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 62. Asia Pacific Prescription Dermatological Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Prescription Dermatological Drugs Sales Market Share by Region in 2019
Figure 64. Asia Pacific Prescription Dermatological Drugs Revenue Market Share by Region in 2019
Figure 65. China Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. China Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Japan Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. South Korea Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. India Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Australia Prescription Dermatological Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Prescription Dermatological Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Taiwan Prescription Dermatological Drugs R

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs